Matthew Balanda
Family · New Haven, CTNPI 1447651690
Payments from drug & device makers
Across 122 payments — averaging $27.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pharming Healthcare, Inc.$1K
- GSK$370
- Pfizer$300
- CSL Behring$228
- AstraZeneca$220
- AbbVie$166
- plus $886 from 15 others
What the payments were for
- Speaking & faculty fees$1,12534%
- Food & beverage$2,00360%
- Education$2106%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pharming Healthcare, Inc. | 3 | $1,168 |
| GSK | 28 | $370 |
| Pfizer | 15 | $300 |
| CSL Behring | 11 | $228 |
| AstraZeneca | 11 | $220 |
| AbbVie | 8 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $163 |
| Boehringer Ingelheim | 9 | $155 |
| Biocryst US Sales Co., LLC | 5 | $104 |
| Genentech USA, Inc. | 5 | $103 |
| Regeneron Healthcare Solutions, Inc. | 3 | $77 |
| Sanofi | 3 | $60 |
| Aimmune Therapeutics, Inc. | 3 | $58 |
| LEO Pharma Inc. | 3 | $46 |
| Optinose US, Inc. | 1 | $22 |
| Incyte Corporation | 1 | $21 |
| Covis Pharma GmbH | 1 | $20 |
| Kaleo, Inc. | 1 | $18 |
| Phadia US Inc. | 1 | $15 |
| ADMA Biomanufacturing LLC | 1 | $12 |
| Alk-abello, Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RUCONEST$1,125
How this compares
$3,338 in reported general payments places this provider in the 85th percentile of 1,596 family providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Montelukast Sodium | 13 | $204 |
Paid to pharmacies, not to this prescriber.
Other family in New Haven
- Dayna GiordanoNew Haven$65K
- Alicia BurrNew Haven$17K
- Michael TawiahNew Haven$10K
- Elisha ChristiansonWaterbury$371K
- Kathryn TierneyNew Britain$140K
- Jennifer SilvaSouth Windsor$91K
- Carli WillardEnfield$74K
- Erin MartinMilford$70K
- Diana BytyqiDerby$53K
- Farhiya AbdiSouth Windsor$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.